Dr. Ruslan Medzhitov's lab at Yale University studies Immunoglobulin E (IgE), a type of antibody that plays a crucial role in the immune response. While IgE is well-known for causing allergies, the lab is interested in understanding its functions in maintaining health and fighting diseases. They aim to identify specific antigens that IgE responds to and how these interactions influence the body's response during infections and inflammation.

Dr. Georges El Fakhri's lab at Yale University focuses on advancing imaging technologies in healthcare, particularly using PET (Positron Emission Tomography) for improved diagnosis and treatment of diseases like cancer and Alzheimer's. The lab’s research includes developing new PET scanner designs, enhancing methods for quantifying tau protein in the brain associated with Alzheimer's, and using deep learning to personalize treatment plans for prostate cancer patients receiving radionuclide therapy. Their work aims to improve patient outcomes through better imaging and treatment strategies.

Dr. Gisela Gabernet's lab at Yale University focuses on developing advanced computational tools for analyzing immune system data, particularly related to B cell and T cell responses. The lab works on processing high-throughput sequencing data to better understand immune reactions to infections and diseases, creating user-friendly software tools to help other researchers. By making data analysis easier and more accessible, the lab aims to enhance research in infectious diseases and immune-mediated conditions.

Dr. Yong-Hui Jiang's lab at Yale University focuses on understanding genetic factors that contribute to recurrent pregnancy loss and developing new gene editing techniques to treat neurogenetic diseases. Their innovative research employs large-scale genomic studies to identify genetic predictors of pregnancy complications and explores non-viral CRISPR delivery systems to enable targeted therapies for conditions like Angelman syndrome. The lab also collaborates with a network that aims to accelerate the diagnosis of undiagnosed diseases through advanced genomic technologies.

Dr. Nikhil Joshi's lab studies how immune cells called CD8 T cells develop and respond to tumors, particularly in lung cancer. His research focuses on the tumor-draining lymph node, where these cells are maintained, and investigates the signals that can either enhance their ability to fight tumors or lead to their dysfunction. They use advanced techniques to manipulate the immune cells genetically and analyze their behavior at the single-cell level.

Dr. Ailong Ke's lab at Yale University focuses on understanding the intricate roles of RNA in gene regulation and immunity using advanced techniques in biophysics and molecular genetics. The lab aims to develop new biotechnological applications, including RNA-based genome editing tools like CRISPR. By studying the structure and function of riboswitches, the research also seeks to identify new antibiotic targets relevant to human health.

Dr. Anthony Koleske's lab at Yale University focuses on understanding the role of the TRIO gene in neurodevelopmental disorders like autism and schizophrenia. The lab investigates how specific genetic variants affect TRIO protein function and aims to identify small molecules to modulate its activity as potential therapeutic strategies. Through biochemical assays and advanced cell models, the lab seeks to elucidate the underlying mechanisms of neuronal development influenced by TRIO.

Dr. Valerie J. Reinke's research focuses on understanding how the organization of chromatin in germ cells influences embryonic development. By studying the roundworm C. elegans, her lab aims to uncover the mechanisms that regulate gene expression and chromatin dynamics during key processes like fertilization and early development. These insights could have important implications for understanding genetic regulation in humans and addressing developmental diseases.

The lab led by Assaf Alon at Yale University focuses on understanding the roles of the EXPERA family of proteins in cholesterol and lipid metabolism. These proteins, including the sigma-2 receptor and TM6SF2, are significant in various diseases such as cancer, Alzheimer's, and metabolic disorders. The lab employs structural biology techniques to explore protein interactions and develop therapeutic strategies that could lead to novel treatments.

Dr. Maria Lara-Tejero's lab at Yale University studies the machinery that some harmful bacteria use to infect host cells. Her team is focused on understanding how these bacteria inject proteins into host cells, which is crucial for their ability to cause disease. By using advanced imaging and genetic techniques, they seek to uncover details about this process that could help in developing new ways to combat bacterial infections.

Dr. Wenwei Li's lab at Yale University focuses on understanding how the HIV-1 virus fuses with host cells to initiate infection. They use advanced imaging techniques, particularly cryo-electron tomography, to visualize the interactions between the virus and cell membranes. The goal of this research is to uncover critical details about how HIV-1 proteins interact and change shape during the fusion process, which could lead to new treatments for HIV infection.

Dr. Janghoo Lim's lab at Yale University focuses on understanding the causes and mechanisms behind neurodegenerative diseases, such as Alzheimer's and spinocerebellar ataxia. They study how specific proteins and genetic mutations affect brain cells, particularly oligodendrocytes, which are vital for nervous system health. Their research aims to reveal new pathways for potential therapies by exploring how these proteins can be targeted to slow down or prevent disease progression.

Dr. Christopher G. Burd's lab at Yale University focuses on understanding how lipids are distributed and modified in different parts of the cell, particularly in the Golgi apparatus. By studying these processes, the lab aims to uncover new insights into how cells regulate their internal environment, which can be crucial for understanding various diseases, including cancer and neurodegenerative disorders like Alzheimer's. The research has implications for improving our knowledge of cell function and potential therapeutic targets.

The lab of Dr. Jun Liu at Yale University focuses on understanding how certain bacteria, particularly Helicobacter pylori and spirochetes, manage to move and infect hosts. By studying unique structures called sheathed flagella, which help these bacteria navigate their environments, the lab aims to uncover new ways to combat infections linked to diseases like ulcers and Lyme disease. The research combines advanced imaging techniques with genetic and biochemical methods to reveal insights that could lead to new antibacterial therapies.

Jun Lu's research lab at Yale focuses on understanding the role of cell surface RNAs, specifically in neutrophils — critical immune cells that respond to inflammation. The lab investigates glycosylated RNAs, known as glycoRNAs, which are found on the surface of these cells and may influence how neutrophils interact with blood vessels and tissues. This research has the potential to reveal new mechanisms of immune response regulation and contribute to our knowledge of human diseases related to inflammation.

Dr. Carrie L. Lucas' lab at Yale University focuses on understanding how certain immune cells produce antibodies to fight infections. By studying a specific enzyme called PI3K-gamma, the lab investigates its role in B cells, the cells responsible for antibody production. The research efforts aim to uncover how defects in this pathway can lead to severe immune problems and explore potential new treatments for related diseases.

Dr. Kurt A Schalper's lab at Yale University focuses on studying the immune environment in lung cancer to improve diagnosis and treatment. We analyze how immune cells interact with tumors to better select which patients will benefit from immunotherapy. By investigating the characteristics of tumors and their surrounding immune cells, the research aims to develop more effective cancer treatments.

Rong Fan's research lab at Yale University focuses on understanding non-Hodgkin lymphomas, particularly how follicular lymphoma transforms into more aggressive forms. Using cutting-edge technologies in single-cell and spatial omics, the lab maps the complex interactions between different cell types in tumors to identify potential biomarkers and therapeutic targets. Their work aims to build a comprehensive atlas of lymphomas, which will help in predicting disease progression and improving patient treatment strategies.

Dr. Chao Ma's lab focuses on enhancing the treatment of gliomas, a common type of malignant brain tumor, through advanced imaging techniques. They are developing a novel imaging technology that combines Magnetic Resonance Spectroscopic Imaging (MRSI) with machine learning to achieve high-resolution metabolic images of tumors. This research aims to improve the accuracy of radiation therapy planning by precisely mapping tumor boundaries, which is crucial for better patient outcomes in glioma treatment.

Dr. Graeme F. Mason's lab at Yale University studies how alcohol affects brain metabolism, particularly the role of acetate, a byproduct of alcohol, in energy use and stress responses. The research aims to understand how acetate influences brain structure and behavior in individuals who drink alcohol, including heavy and dependent drinkers. The lab also explores potential therapeutic interventions for alcohol dependence, focusing on metabolic adaptations and brain health.